Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Atreca revenue
Atreca's revenue is $1.4 million.
What is Atreca's revenue?
- Atreca has 130 employees, and the revenue per employee ratio is $10,923.
- Atreca peak revenue was $1.4M in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Atreca financial information
| CEO | John A. Orwin |
| Industry | Commercial & Professional Services |
| Company Type | Public |
| Employees Number | 130 |
| Date Founded | 2011 |
| Headquarters | Redwood City, California |
| Revenue | $1.4M |
| Net Income | -$97,157,000 |
| Tax Rate | 0.0% |
| Total Assets | $155,030,000 |
| Ticker | BCEL |
Atreca jobs you might like
Atreca financing
Atreca received early financing of $160.0K on 2011-10-18.
| Series | Round size | Date |
|---|---|---|
| Debt Financing | $160K | 10/2011 |
| Series Unknown | $6M | 09/2012 |
| Debt Financing | $700K | 08/2013 |
| Series A | $56M | 11/2015 |
| Series B | $35M | 08/2017 |
| Series C | $125M | 09/2018 |
Atreca investors
| Investors | Security type |
|---|---|
| Bill & Melinda Gates Foundation | Series Unknown |
| GlaxoSmithKline plc | Series A |
| Evolution VC Partners | Series A |
| Mission Bay Capital | Series A |
| Bill & Melinda Gates Foundation | Series A |
| Wellington Management | Series B |
| Cormorant Asset Management | Series B |
| Mission BioCapital | Series B |
| Tavistock Group | Series C |
| EcoR1 Capital, LLC | Series C |
| Redmile Group | Series C |
| Tekla Capital Management | Series C |
| Wellington Management | Series C |
| Cormorant Asset Management | Series C |
| Samsara BioCapital | Series C |
| Boxer Capital | Series C |
| Aisling Capital | Series C |
Atreca competitors
Atreca's top competitor, Mersana Therapeutics, earned an annual revenue of $40.5M.
Atreca's smallest competitor is Eureka Therapeutics with revenue of $500.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Bird Rock Bio | - | $5.0M | 3 | - |
| Eureka Therapeutics | - | $500,000 | 50 | - |
| AbVitro | - | $10.0M | 350 | - |
| Mersana Therapeutics | - | $40.5M | 169 | - |
| Bolt Biotherapeutics | - | $7.7M | 91 | - |
| Apexigen | - | $4.9M | 39 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Atreca highest paying jobs
Zippia gives an in-depth look into the details of Atreca, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Atreca. The employee data is based on information from people who have self-reported their past or current employments at Atreca. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Atreca. The data presented on this page does not represent the view of Atreca and its employees or that of Zippia.
Atreca may also be known as or be related to ATRECA, INC., Atreca and Atreca, Inc.